SS Innovations International, Inc. (SSII)
| Market Cap | 500.96M -62.8% |
| Revenue (ttm) | 52.40M +89.7% |
| Net Income | -12.43M |
| EPS | -0.06 |
| Shares Out | 200.39M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 9,382 |
| Open | 2.540 |
| Previous Close | 2.550 |
| Day's Range | 2.420 - 2.540 |
| 52-Week Range | 2.420 - 10.000 |
| Beta | 0.73 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Oct 27, 2026 |
About SSII
SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NADI – Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applica... [Read more]
Financial Performance
In 2025, SSII's revenue was $42.48 million, an increase of 105.74% compared to the previous year's $20.65 million. Losses were -$12.13 million, -36.68% less than in 2024.
Financial StatementsNews
SS Innovations submits response to FDA request for additional information
SS Innovations (SSII) announced that the company submitted its response to a request for additional information letter received from the FDA with regard to the company’s 510 submission for its…
SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company's 510(k) Submission for the SSi Mantra
FORT LAUDERDALE, Fla., Oct. 13, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic te...
SS Innovations Provides Update on Continuing Progress and Milestones
-- Advancing global expansion, pediatric robotic surgery and telesurgery -- -- Growing SSi Mantra installations, procedures and utilization -- FORT LAUDERDALE, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) --...
SS Innovations Reports Second Quarter 2026 Financial Results
Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales
SS Innovations International Quarterly report: Q2 2026
SS Innovations International has published its Q2 2026 quarterly earnings report on August 13, 2026.
SS Innovations International Earnings release: Q2 2026
SS Innovations International released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026
Company's advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event Compan...
SS Innovations appoints Sarah Romano as CFO
SS Innovations (SSII) announced the appointment of Sarah Romano as CFO, effective August 3. Romano will be based in the United States. Most recently, Romano served as CFO of Vicarious…
SS Innovations Appoints Sarah M. Romano as Chief Financial Officer
Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth Veteran medtech finance executive brings extensive...
SS Innovations Subsidiary SSICRS Graduates Inaugural Cardiac Robotic Surgery Training Class
New course empowers healthcare professionals through expert instruction and hands-on learning New course empowers healthcare professionals through expert instruction and hands-on learning
IBN Initiates Coverage of SS Innovations International, Inc.
AUSTIN, Texas, July 07, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surge...
SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards
Company celebrated for advancing global access to its innovative robotic surgery platform Company celebrated for advancing global access to its innovative robotic surgery platform
SS Innovations International Quarterly report
SS Innovations International has published a quarterly earnings report on June 15, 2026.
SS Innovations International Slides: Investor presentation
SS Innovations International has posted slides in relation to its latest quarterly earnings report, which was published on June 12, 2026.
SS Innovations initiated with a Buy at Lucid Capital
Lucid Capital analyst Alex Nowak initiated coverage of SS Innovations (SSII) with a Buy rating and $7 price target The company’s SSi Mantra 3 is a clinically validated, multi-specialty platform…
UBERDOC Health Technologies Announces Appointment of John Dvor to Board of Directors
Board Appointment Enhances UberDoc's Strategic Positioning in the Rapidly Growing Direct-Pay Healthcare Market Boston, Massachusetts--(Newsfile Corp. - May 19, 2026) - UBERDOC Health Technologies (CSE...
SS Innovations International Quarterly report: Q1 2026
SS Innovations International has published its Q1 2026 quarterly earnings report on May 13, 2026.
SS Innovations International Earnings release: Q1 2026
SS Innovations International released its Q1 2026 earnings on May 13, 2026, summarizing the period's financial results.
SS Innovations performs over 10,500 cumulative surgeries with Mantra system
SS Innovations (SSII) announced that more than 10,500 cumulative surgeries have been successfully performed with the company’s SSi Mantra surgical robotic system. As of April 30, the cumulative number...
SS Innovations files to sell 5.02M shares of common stock for holders
16:26 EDT SS Innovations (SSII) files to sell 5.02M shares of common stock for holders
SS Innovations files $150M mixed securities shelf
16:26 EDT SS Innovations (SSII) files $150M mixed securities shelf
SS Innovations International Registration statement: Registration filing
SS Innovations International filed a registration statement on May 1, 2026, providing details about a securities offering with the SEC.
SS Innovations gets regulatory approvals for SSi Mantra surgical robotic system
SS Innovations (SSII) announced that the company has received regulatory approval for the SSi Mantra surgical robotic system, for multiple indications in Colombia, Oman, Sri Lanka and Kenya. The compa...
SS Innovations announces new approvals for Mantra surgical robotic system
SS Innovations (SSII) International announced that the Company’s SSi Mantra surgical robotic system has been approved for telesurgeries in Indonesia and the Philippines. The Company today also announc...
SS Innovations International Annual report: Q4 2025
SS Innovations International has published its Q4 2025 annual report on March 10, 2026.